Pharmaron Beijing Co., Ltd.
SZSE:300759.SZ
27.61 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||
| Current Assets: | ||||||||||
| Cash & Cash Equivalents
| 5,918.915 | 1,497.484 | 3,543.82 | 2,942.353 | 4,459.852 | 320.711 | 305.5 | 470.209 | 87.05 | 41.021 |
| Short Term Investments
| 621.983 | 745.362 | 1,554.621 | 910.01 | 183.451 | 0.413 | -253.935 | -201.033 | 0 | 0 |
| Cash and Short Term Investments
| 6,540.899 | 2,242.846 | 5,098.441 | 3,852.363 | 4,643.304 | 321.124 | 305.5 | 470.209 | 87.05 | 41.021 |
| Net Receivables
| 2,636.418 | 2,214.483 | 1,423.83 | 1,210.378 | 946.174 | 655.411 | 542.531 | 390.893 | 249.286 | 185.605 |
| Inventory
| 1,013.079 | 1,041.461 | 680.04 | 281.617 | 157.397 | 120.462 | 93.267 | 92.577 | 47.773 | 30.124 |
| Other Current Assets
| 630.23 | 1,219.826 | 1,441.191 | 196.02 | 257.923 | 179.111 | 171.13 | 143.472 | 50.894 | 63.131 |
| Total Current Assets
| 10,874.413 | 6,536.007 | 8,643.502 | 5,540.378 | 5,944.451 | 1,280.66 | 1,078.175 | 1,097.151 | 435.004 | 341.299 |
| Non-Current Assets: | ||||||||||
| Property, Plant & Equipment, Net
| 10,289.145 | 8,285.75 | 5,667.331 | 3,798.703 | 2,882.287 | 2,376.668 | 2,094.263 | 741.912 | 501.411 | 344.557 |
| Goodwill
| 2,780.918 | 2,687.865 | 2,096.265 | 1,166.172 | 203.286 | 139.917 | 133.524 | 0 | 0 | 0 |
| Intangible Assets
| 789.057 | 802.535 | 692.935 | 566.076 | 420.574 | 389.87 | 302.02 | 21.759 | 21.499 | 22.014 |
| Goodwill and Intangible Assets
| 3,569.974 | 3,490.399 | 2,789.2 | 1,732.249 | 623.859 | 529.787 | 435.544 | 21.759 | 21.499 | 22.014 |
| Long Term Investments
| 1,004.978 | 262.95 | -791.952 | -508.306 | 6.848 | 52.476 | 257.202 | 204.502 | 141.414 | 154.614 |
| Tax Assets
| 153.218 | 58.789 | 15.595 | 8.436 | 6.372 | 6.168 | 7.626 | 5.704 | 6.869 | 9.172 |
| Other Non-Current Assets
| 584.985 | 1,858.662 | 2,065.448 | 1,337.333 | 471.221 | 379.72 | 46.364 | 733.534 | 68.349 | 59.808 |
| Total Non-Current Assets
| 15,602.3 | 13,956.551 | 9,745.622 | 6,368.414 | 3,990.587 | 3,344.819 | 2,840.999 | 1,707.412 | 739.543 | 590.165 |
| Total Assets
| 26,476.713 | 20,492.557 | 18,389.124 | 11,908.793 | 9,935.038 | 4,625.479 | 3,919.174 | 2,804.563 | 1,174.546 | 931.465 |
| Liabilities & Equity: | ||||||||||
| Current Liabilities: | ||||||||||
| Account Payables
| 412.221 | 406.348 | 315.534 | 191.497 | 117.978 | 108.22 | 91.64 | 61.322 | 41.48 | 26.848 |
| Short Term Debt
| 577.071 | 662.767 | 421.757 | 377.265 | 213.951 | 381.845 | 275.091 | 370.246 | 169.808 | 153.073 |
| Tax Payables
| 184.547 | 188.287 | 114.192 | 51.834 | 43.731 | 31.141 | 35.146 | 13.368 | 11.566 | 10.174 |
| Deferred Revenue
| 0 | -0 | 2,075.088 | 473.289 | 636.046 | 31.141 | 270.699 | 206.348 | 671.058 | 343.421 |
| Other Current Liabilities
| 2,480.637 | 2,655.03 | 55.427 | 887.903 | 257.974 | 703.461 | 539.143 | 215.939 | 742.258 | 390.462 |
| Total Current Liabilities
| 3,654.476 | 3,912.433 | 2,981.997 | 1,981.789 | 1,269.681 | 1,255.809 | 941.019 | 660.875 | 965.112 | 580.558 |
| Non-Current Liabilities: | ||||||||||
| Long Term Debt
| 8,784.863 | 5,214.776 | 4,707.523 | 581.419 | 673.188 | 1,021.301 | 1,029.907 | 413.265 | 26.45 | 53.055 |
| Deferred Revenue Non-Current
| 0 | 152.375 | 149.439 | 158.128 | 111.606 | 100.989 | 63.896 | 14.022 | 14.553 | 16.967 |
| Deferred Tax Liabilities Non-Current
| 0 | 261.013 | 173.3 | 106.906 | 40.782 | 23.469 | 11.121 | 0 | -0 | 64.765 |
| Other Non-Current Liabilities
| 799.328 | 112.093 | 81.559 | 146.81 | 3.527 | 146.159 | -137.06 | -33.001 | 0 | -42.125 |
| Total Non-Current Liabilities
| 9,584.191 | 5,740.257 | 5,111.821 | 993.264 | 827.339 | 1,027.751 | 967.864 | 380.264 | 41.003 | 92.662 |
| Total Liabilities
| 13,238.666 | 9,652.69 | 8,093.818 | 2,975.053 | 2,097.02 | 2,283.56 | 1,908.882 | 1,041.139 | 1,006.115 | 673.22 |
| Equity: | ||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 1,787.394 | 1,191.225 | 794.177 | 794.387 | 794.387 | 590.664 | 590.664 | 590.664 | 130.975 | 125 |
| Retained Earnings
| 5,204.512 | 4,152.381 | 3,221.775 | 1,929.024 | 962.22 | 548.265 | 240.996 | 37.866 | -91.612 | -165.458 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 56.504 | 255.73 | 165.151 | 138.367 | 60.727 | 118.168 | 87.357 | 129.068 | 4.317 |
| Other Total Stockholders Equity
| 5,564.891 | 5,205.01 | 6,113.289 | 6,185.133 | 5,892.108 | 1,214.594 | 1,177.841 | 1,129.095 | 129.068 | 298.703 |
| Total Shareholders Equity
| 12,556.797 | 10,548.615 | 10,129.241 | 8,870.32 | 7,767.063 | 2,328.928 | 1,997.674 | 1,763.424 | 168.432 | 258.245 |
| Total Equity
| 13,238.046 | 10,839.868 | 10,295.307 | 8,933.74 | 7,838.018 | 2,341.919 | 2,010.292 | 1,763.424 | 168.432 | 258.245 |
| Total Liabilities & Shareholders Equity
| 26,476.713 | 20,492.557 | 18,389.124 | 11,908.793 | 9,935.038 | 4,625.479 | 3,919.174 | 2,804.563 | 1,174.546 | 931.465 |